Insider Transactions in Q1 2023 at Quidel Ortho Corp (QDEL)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Evelyn S Dilsaver |
BUY
Grant, award, or other acquisition
|
Direct |
68
+11.02%
|
-
|
|
Feb 23
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,527
-1.39%
|
$662,376
$88.71 P/Share
|
|
Feb 23
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,180
+2.72%
|
-
|
|
Feb 17
2023
|
Kenneth F Buechler |
SELL
Open market or private sale
|
Direct |
8,081
-10.31%
|
$727,290
$90.26 P/Share
|
|
Feb 17
2023
|
Kenneth F Buechler |
BUY
Exercise of conversion of derivative security
|
Direct |
8,081
+9.35%
|
$185,863
$23.7 P/Share
|
|
Feb 11
2023
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,705
-2.94%
|
$146,630
$86.5 P/Share
|
|
Feb 11
2023
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,566
+5.7%
|
-
|
|
Feb 11
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,540
-0.43%
|
$390,440
$86.5 P/Share
|
|
Feb 11
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,501
+0.89%
|
-
|
|
Feb 11
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,815
-2.45%
|
$156,090
$86.5 P/Share
|
|
Feb 11
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+4.55%
|
-
|
|
Feb 04
2023
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
4,064
-7.43%
|
$361,696
$89.7 P/Share
|
|
Feb 04
2023
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+13.03%
|
-
|
|
Feb 04
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,282
-1.75%
|
$826,098
$89.7 P/Share
|
|
Feb 04
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,720
+3.4%
|
-
|
|
Feb 04
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,905
-5.25%
|
$169,545
$89.7 P/Share
|
|
Feb 04
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
3,623
+9.08%
|
-
|
|
Feb 03
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,882
-0.37%
|
$167,498
$89.7 P/Share
|
|
Feb 03
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,795
+0.73%
|
-
|
|
Feb 03
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
873
-2.61%
|
$77,697
$89.7 P/Share
|
|
Feb 03
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,660
+4.72%
|
-
|
|
Feb 01
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
553
-0.11%
|
$48,664
$88.51 P/Share
|
|
Feb 01
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,115
+0.22%
|
-
|
|
Feb 01
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-1.43%
|
$40,744
$88.51 P/Share
|
|
Feb 01
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
879
+2.65%
|
-
|
|
Feb 01
2023
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-3.63%
|
$14,256
$88.51 P/Share
|
|
Feb 01
2023
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
473
+9.58%
|
-
|
|
Feb 01
2023
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
651
-2.84%
|
$57,288
$88.51 P/Share
|
|
Feb 01
2023
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
1,312
+5.42%
|
-
|
|
Jan 31
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,406
-0.66%
|
$289,510
$85.61 P/Share
|
|
Jan 31
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,760
+1.3%
|
-
|
|
Jan 31
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,771
-5.33%
|
$150,535
$85.61 P/Share
|
|
Jan 31
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
3,219
+8.84%
|
-
|
|
Jan 31
2023
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
643
-13.88%
|
$54,655
$85.61 P/Share
|
|
Jan 31
2023
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,609
+25.78%
|
-
|
|
Jan 31
2023
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,840
-7.87%
|
$156,400
$85.61 P/Share
|
|
Jan 31
2023
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,547
+13.17%
|
-
|